India  

Covaxin effective against double mutant strain found in India: ICMR study

IndiaTimes Wednesday, 21 April 2021
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Covaxin Covaxin Vaccine against COVID-19

Covaxin trial for 2-18 yrs age group to begin in 10-12 days, govt says

Trial of Bharat Biotech's Covaxin in the 2-18 years age group is likely to begin in the next 10-12 days., a govt official said. The vaccine received DCGI..
IndiaTimes

COVID-19: Covaxin gets approval for phase 2-3 clinical trials for 2-18 age group, to begin in next 10-12 days

Phase 2-3 clinical trials of Covaxin, which has been approved by the DCGI for in the age group of 2 to 18 years, will begin in 10 to 12 days.
DNA

Clot cases post-Covishield jab miniscule: Govt panel

Blood clots or thromboembolic events after vaccination with Covishield were reported in just 0.61 cases per million doses in India, while no such events were..
IndiaTimes
Jharkhand Police: ₹ 35 lakh as fine from masses violating Covid norms  | Oneindia News [Video]

Jharkhand Police: ₹ 35 lakh as fine from masses violating Covid norms | Oneindia News

Thousands of people including Covid patients evacuated because of Cyclone Tauktae from Gujarat and Maharashtra; Bharat Biotech said that the company manufactured Covaxin is effective against the aggressively virulent strains of Covid detected in India and in the UK; Delhi police said that an Aam Admi Party party member is the brain behind the posters that appeared around parts of Delhi a few days ago; Delhi Chief Minister Arvind Kejriwal today said the Delhi government will take all necessary steps and precautions to check cases of black fungus or mucormycosis in the city; Jharkhand Police has collected over ₹ 35 lakh as fine from people for not wearing masks in public places. #CycloneTauktae #Covaxin #AAP #BlackFungus #JharkhandPolice

Credit: Oneindia    Duration: 03:39Published

Indian Council of Medical Research Indian Council of Medical Research Government Organization

Plasma therapy no longer part of Covid-19 treatment, says ICMR

The use of convalescent plasma therapy for treating Covid patients has been dropped from Clinical Management Guidelines, the Indian Council of Medical Research..
IndiaTimes

Uttar Pradesh chief minister Yogi Adityanath visits Aligarh Muslim University after several faculty deaths

Uttar Pradesh chief minister Yogi Adityanath on Thursday visited AMU’s Jawaharlal Nehru Medical College to review the prevailing Covid-19 situation in the..
IndiaTimes

Covid-19: Most of country should remain locked down for 6-8 weeks, ICMR chief says

The head of the main Indian health agency responding to the coronavirus has said districts reporting a high number of infections should remain locked down for..
IndiaTimes

Related videos from verified sources

Watch Delhi airport react to news that US is banning travel from India due to 'double mutant' COVID [Video]

Watch Delhi airport react to news that US is banning travel from India due to 'double mutant' COVID

Passengers filled Delhi's Indira Gandhi International Airport late Friday night (April 30) as the "double mutant" strain of Covid-19 rages in India and residents fear increasing travel bans for interna

Credit: Newsflare STUDIO     Duration: 00:59Published
COVID: 'More variants to emerge in India as infections spread', says CCMB Director [Video]

COVID: 'More variants to emerge in India as infections spread', says CCMB Director

CSIR-Centre for Cellular and Molecular Biology (CCMB) Director Dr Rakesh Mishra raised alarm bells over rising cases of COVID and said that as infections increase more variants may emerge in India. "In..

Credit: ANI     Duration: 01:45Published
‘Double Mutant' COVID-19 variant discovered in the Bay Area [Video]

‘Double Mutant' COVID-19 variant discovered in the Bay Area

A "double mutant" COVID-19 strain that was first identified in India has now been found in California. While this case may be the first here in the US, seven more are suspected.

Credit: WXYZ Detroit     Duration: 03:17Published